WO2023010083 - RECOMBINANT PRENYLTRANSFERASE POLYPEPTIDES ENGINEERED FOR ENHANCED BIOSYNTHESIS OF CANNABINOIDS
National phase entry:
Publication Number
WO/2023/010083
Publication Date
02.02.2023
International Application No.
PCT/US2022/074264
International Filing Date
28.07.2022
Title **
[English]
RECOMBINANT PRENYLTRANSFERASE POLYPEPTIDES ENGINEERED FOR ENHANCED BIOSYNTHESIS OF CANNABINOIDS
[French]
POLYPEPTIDES DE PRÉNYLTRANSFÉRASE RECOMBINANTS MIS AU POINT POUR UNE BIOSYNTHÈSE AMÉLIORÉE DE CANNABINOÏDES
Applicants **
WILLOW BIOSCIENCES, INC.
EPIMERON USA, INC.
Inventors
CHOUDHARY, Trish
FENG, Xueyang
PASSAIA PRIETSCH, Gisele
Priority Data
63/227,747
30.07.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3159 | |
| EPO | Filing, Examination, Granting | 20239 | |
| Japan | Filing, Examination, Granting | 2797 | |
| South Korea | Filing, Examination, Granting | 3171 | |
| USA | Filing, Examination, Granting | 21790 |
Total:
51,156
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present disclosure relates to recombinant polypeptides that have prenyltransferase activity, nucleic acids encoding these recombinant polypeptides, recombinant host cells that produce these recombinant polypeptides, and compositions comprising the recombinant polypeptides, nucleic acids, and/or recombinant host cells. The present disclosure also relates to uses of these recombinant polypeptides, nucleic acids encoding them, and recombinant host cells comprising them, in methods for the preparation of cannabinoids.[French]
La présente divulgation concerne des polypeptides recombinants qui ont une activité de prényltransférase, des acides nucléiques codant ces polypeptides recombinants, des cellules hôtes recombinantes qui produisent ces polypeptides recombinants, et des compositions contenant les polypeptides recombinants, des acides nucléiques et/ou des cellules hôtes recombinantes. La présente divulgation concerne également des utilisations de ces polypeptides recombinants, des acides nucléiques les codant, et des cellules hôtes recombinantes les contenant, dans des procédés de préparation de cannabinoïdes.